# EDGAR Filing Document

**Accession Number:** 0000811222
**File Stem:** 0001683168-25-009166
**Filing Date:** 2025-12
**Character Count:** 9650
**Document Hash:** 965b931819e339a3d6402862247375b8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-009166.hdr.sgml**: 20251215

**ACCESSION NUMBER**: 0001683168-25-009166

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250409

**FILED AS OF DATE**: 20251215

**DATE AS OF CHANGE**: 20251215

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Cunningham Alex H.
- **CENTRAL INDEX KEY:** 0002013098

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-49709
- **FILM NUMBER:** 251572846

**MAIL ADDRESS:**
- **STREET 1:** 3753 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cardiff Lexington Corp
- **CENTRAL INDEX KEY:** 0000811222
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 841044583
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3753 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169
- **BUSINESS PHONE:** 844-628-2100

**MAIL ADDRESS:**
- **STREET 1:** 3753 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CARDIFF INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 20000211

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** UNITED AMERICAN INC
- **DATE OF NAME CHANGE:** 19910924

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CARDIFF FINANCIAL INC
- **DATE OF NAME CHANGE:** 19890510

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Cunningham Alex H.<br><sub>(Last) (First) (Middle)</sub><br>3753 HOWARD HUGHES PARKWAY, SUITE 200<br><sub>(Street)</sub><br>LAS VEGAS, NV 89169<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-04-09 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Cardiff Lexington Corp [ CDIX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-04-24 |  | C<sup>(2)</sup> |  | 1050000 | A | $0 | 2072838 | D |  |
| Common Stock | 2025-04-24 |  | C<sup>(3)</sup> |  | 270000 | A | $0 | 2342838 | D |  |
| Common Stock | 2025-04-24 |  | C<sup>(4)</sup> |  | 154000 | A | $0 | 2496838 | D |  |
| Common Stock | 2025-09-08 |  | J<sup>(5)</sup> |  | 2496834 | D | $0 | 4 | D |  |
| Common Stock | 2025-09-08 |  | J<sup>(5)</sup> |  | 2496834 | A | $0 | 2496834 | I | Held by Alexander Hunt Cunningham, Sr. Revocable Trust |
| Common Stock | 2025-11-19 |  | C<sup>(6)</sup> |  | 10073092 | A | $0 | 10073096 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Series I Preferred Stock | <sup>(7)</sup> | 2025-04-09 |  | J<sup>(1)</sup> |  |  | 195750 | 2018-11-21 | <sup>(7)</sup> | Common Stock | 391500 | $0.00 | 5036546 | D |  |
| Series B Preferred Stock | <sup>(8)</sup> | 2025-04-09 |  | J<sup>(1)</sup> |  | 150000 |  | 2025-04-09 | <sup>(8)</sup> | Common Stock | 300000 | $0.00 | 525000 | D |  |
| Series C Preferred Stock | <sup>(9)</sup> | 2025-04-09 |  | J<sup>(1)</sup> |  | 3 |  | 2025-04-09 | <sup>(9)</sup> | Common Stock | 30000 | $0.00 | 27 | D |  |
| Series E Preferred Stock | <sup>(10)</sup> | 2025-04-09 |  | J<sup>(1)</sup> |  | 27000 |  | 2025-04-09 | <sup>(10)</sup> | Common Stock | 54000 | $0.00 | 77000 | D |  |
| Series B Preferred Stock | <sup>(8)</sup> | 2025-04-24 |  | C<sup>(2)</sup> |  |  | 525000 | 2025-04-09 | <sup>(8)</sup> | Common Stock | 1050000 | $0.00 | 0 | D |  |
| Series C Preferred Stock | <sup>(9)</sup> | 2025-04-24 |  | C<sup>(3)</sup> |  |  | 27 | 2025-04-09 | <sup>(9)</sup> | Common Stock | 270000 | $0.00 | 0 | D |  |
| Series E Preferred Stock | <sup>(10)</sup> | 2025-04-24 |  | C<sup>(4)</sup> |  |  | 77000 | 2025-04-09 | <sup>(10)</sup> | Common Stock | 154000 | $0.00 | 0 | D |  |
| Series I Preferred Stock | <sup>(7)</sup> | 2025-11-19 |  | C<sup>(6)</sup> |  |  | 5036546 | 2018-11-21 | <sup>(7)</sup> | Common Stock | 10073092 | $0.00 | 0 | D |  |

---

### Footnotes:

(1) On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

(2) On April 24, 2025, all shares of Series B Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(3) On April 24, 2025, all shares of Series C Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(4) On April 24, 2025, all shares of Series E Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(5) On September 8, 2025, the Reporting Person transferred 2,496,834 shares of Common Stock to Alexander Hunt Cunningham, Sr. Revocable Trust, of which the Reporting Person is the Trustee.

(6) On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(7) Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

(8) Each share of Series B Preferred Stock is convertible into two (2) shares of Common Stock. The Series B Preferred Stock has no expiration date.

(9) Each share of Series C Preferred Stock is convertible into 10,000 shares of Common Stock. The Series C Preferred Stock has no expiration date.

(10) Each share of Series E Preferred Stock is convertible into two (2) shares of Common Stock. The Series E Preferred Stock has no expiration date.

**Signature:** /s/ Alex Cunningham  
**Date:** 2025-12-15

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**